234 related articles for article (PubMed ID: 18768876)
1. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination.
Kaufman DR; Liu J; Carville A; Mansfield KG; Havenga MJ; Goudsmit J; Barouch DH
J Immunol; 2008 Sep; 181(6):4188-98. PubMed ID: 18768876
[TBL] [Abstract][Full Text] [Related]
2. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
3. Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys.
Li H; Liu J; Carville A; Mansfield KG; Lynch D; Barouch DH
J Virol; 2011 Nov; 85(21):11007-15. PubMed ID: 21917969
[TBL] [Abstract][Full Text] [Related]
4. Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.
Bassett JD; Swift SL; Bramson JL
Expert Rev Vaccines; 2011 Sep; 10(9):1307-19. PubMed ID: 21919620
[TBL] [Abstract][Full Text] [Related]
5. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
[TBL] [Abstract][Full Text] [Related]
6. Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
Tritel M; Stoddard AM; Flynn BJ; Darrah PA; Wu CY; Wille U; Shah JA; Huang Y; Xu L; Betts MR; Nabel GJ; Seder RA
J Immunol; 2003 Sep; 171(5):2538-47. PubMed ID: 12928404
[TBL] [Abstract][Full Text] [Related]
7. Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.
Kaufman DR; Bivas-Benita M; Simmons NL; Miller D; Barouch DH
J Virol; 2010 Jun; 84(12):5986-96. PubMed ID: 20357087
[TBL] [Abstract][Full Text] [Related]
8. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
[TBL] [Abstract][Full Text] [Related]
9. Mucosal and systemic SIV-specific cytotoxic CD4
Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C
Sci Rep; 2019 Apr; 9(1):5661. PubMed ID: 30952887
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.
Santosuosso M; Zhang X; McCormick S; Wang J; Hitt M; Xing Z
J Immunol; 2005 Jun; 174(12):7986-94. PubMed ID: 15944305
[TBL] [Abstract][Full Text] [Related]
11. Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.
Masek-Hammerman K; Li H; Liu J; Abbink P; La Porte A; O'Brien KL; Whitney JB; Carville A; Mansfield KG; Barouch DH
J Virol; 2010 Oct; 84(19):9810-6. PubMed ID: 20686023
[TBL] [Abstract][Full Text] [Related]
12. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
Peters C; Peng X; Douven D; Pan ZK; Paterson Y
J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365
[TBL] [Abstract][Full Text] [Related]
13. Systemic vaccination induces clonally diverse SIV-specific CD8+ T-cell populations in systemic and mucosal compartments.
Sircar P; Furr KL; Letvin NL
Mucosal Immunol; 2013 Jan; 6(1):93-103. PubMed ID: 22763409
[TBL] [Abstract][Full Text] [Related]
14. Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors.
Barratt-Boyes SM; Soloff AC; Gao W; Nwanegbo E; Liu X; Rajakumar PA; Brown KN; Robbins PD; Murphey-Corb M; Day RD; Gambotto A
J Gen Virol; 2006 Jan; 87(Pt 1):139-149. PubMed ID: 16361426
[TBL] [Abstract][Full Text] [Related]
15. Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge.
Zheng X; Oduro JD; Boehme JD; Borkner L; Ebensen T; Heise U; Gereke M; Pils MC; Krmpotic A; Guzmán CA; Bruder D; Čičin-Šain L
PLoS Pathog; 2019 Sep; 15(9):e1008036. PubMed ID: 31525249
[TBL] [Abstract][Full Text] [Related]
16. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
17. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination.
Holst PJ; Ørskov C; Thomsen AR; Christensen JP
J Immunol; 2010 Apr; 184(8):4431-9. PubMed ID: 20212099
[TBL] [Abstract][Full Text] [Related]
18. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
Fitzgerald JC; Gao GP; Reyes-Sandoval A; Pavlakis GN; Xiang ZQ; Wlazlo AP; Giles-Davis W; Wilson JM; Ertl HC
J Immunol; 2003 Feb; 170(3):1416-22. PubMed ID: 12538702
[TBL] [Abstract][Full Text] [Related]
19. Differences between T cell epitopes recognized after immunization and after infection.
Vogel TU; Horton H; Fuller DH; Carter DK; Vielhuber K; O'Connor DH; Shipley T; Fuller J; Sutter G; Erfle V; Wilson N; Picker LJ; Watkins DI
J Immunol; 2002 Oct; 169(8):4511-21. PubMed ID: 12370388
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge.
Tan X; Sande JL; Pufnock JS; Blattman JN; Greenberg PD
J Virol; 2011 Aug; 85(16):8316-27. PubMed ID: 21653670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
